书目名称 | Oral Pharmacotherapy for Male Sexual Dysfunction | 副标题 | A Guide to Clinical | 编辑 | Gregory A. Broderick | 视频video | | 概述 | Includes supplementary material: | 丛书名称 | Current Clinical Urology | 图书封面 |  | 描述 | For the generation that reached sexual maturity in the 1960s, the “pill” became synonymous with sexual freedom and started a sexual revolution. For women it meant freedom from the fear of pregnancy, and for men enhanced sexual opportunity. The new era of the pill has nothing to do with fertility, but everything to do with sex. The first orally effective prescr- tion drug for treating erectile dysfunction (ED) was marketed in 1998. ® Sildenafil (Viagra ) has rejuvenated the aging male veterans of the sexual revolution, forever changed the science of sexual medicine, and tra- formed society’s perspective on aging and sex. This class of drugs, known as oral phosphodiesterase inhibitors (PDE-type 5), is highly effective in the treatment of ED. Since its introduction there has been a much greater awa- ness of ED, its comorbidities, and its effects on the quality of life. In 1997, while preparing to address the Endocrine Society on the occasion of the 92nd American Urological Association meeting, I first looked at the p- clinical studies of sildenafil. I thought “this will change everything” and it clearly has—changing practice patterns in sexual medicine, and the at- tudes of patients, | 出版日期 | Book 2005 | 关键词 | Internist; assessment; patients; primary care; quality; safety | 版次 | 1 | doi | https://doi.org/10.1385/1592598714 | isbn_softcover | 978-1-61737-578-1 | isbn_ebook | 978-1-59259-871-7Series ISSN 2197-7194 Series E-ISSN 2197-7208 | issn_series | 2197-7194 | copyright | Humana Press 2005 |
The information of publication is updating
|
|